Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study

Lie, Ingrid Anne; Kacar, Sezgi; Wesnes, Kristin; Brouwer, Iman; Kvistad, Silje S.; Wergeland, Stig; Holmøy, Trygve; Midgard, Rune; Bru, Alla Nikolajevna S; Edland, Astrid; Eikeland, Randi; Gosal, Sonia; Harbo, Hanne-Cathrin Flinstad; Kleveland, Grethe; Sørenes, Yvonne; Øksendal, Nina; Varhaug, Kristin Nielsen; Vedeler, Christian Alexander; Barkhof, Frederik; Teunissen, Charlotte E.; Bø, Lars; Torkildsen, Øivind Fredvik Grytten; Myhr, Kjell-Morten; Vrenken, Hugo
Peer reviewed, Journal article
Published version
Thumbnail
View/Open
URI
https://hdl.handle.net/11250/3021301
Date
2022
Metadata
Show full item record
Collections
Original version
Lie, I. A., Kacar, S., Wesnes, K., Brouwer, I., Kvistad, S. S.,Wergeland, S., Holmøy, T., Midgard, R., Bru, A. N. S., Edland, A., Eikeland, R., Gosal, S., Harbo, H.- C. F., Kleveland, G., Sørenes, Y., Øksendal, N., Varhaug, K. N., Vedeler, C. A., Barkhof, F., Teunissen, C. E., Bø, L., Torkildsen, Ø. F. G., Myhr, K-M. & Vrenken, H. (2022). Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. Journal of Neurology, Neurosurgery and Psychiatry, 93 (8), 1-9.   10.1136/jnnp-2021-328568
Publisher
BMJ Publishing Group
Journal
Journal of Neurology, Neurosurgery and Psychiatry
Copyright
© 2022 The Author(s)
Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal